(Q42910043)

English

Comment on "ahead of its time? Reflecting on New Zealand's Pharmac following its 20th anniversary" : clarification from PHARMAC: PHARMAC takes no particular distributive approach (utilitarian or otherwise)

scientific article published in October 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Comment on "ahead of its time? Reflecting on New Zealand's Pharmac following its 20th anniversary" : clarification from PHARMAC: PHARMAC takes no particular distributive approach (utilitarian or otherwise). (English)

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

1

object named as

Scott Metcalfe

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

author name string

Rachel Grocott

2

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Dilky Rasiah

3

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

publication date

1 October 2014

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

32

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

10

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

1031-1033

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

copyright license

Creative Commons Attribution-NonCommercial 4.0 International

11 September 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Comments on "Simoens, S. Health economic assessment: a methodological primer. Int. J. Environ. Res. Public Health 2009, 6, 2950-2966"-New Zealand in fact has no cost-effectiveness threshold

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

27 May 2018

Explicit incorporation of equity considerations into economic evaluation of public health interventions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

27 May 2018

QALY maximisation and people's preferences: a methodological review of the literature.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

27 May 2018

Resource allocation, social values and the QALY: a review of the debate and empirical evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

27 May 2018

Equity in health: the importance of different health streams

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

27 May 2018

Double jeopardy, the equal value of lives and the veil of ignorance: a rejoinder to Harris

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

27 May 2018

Double jeopardy and the veil of ignorance--a reply

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

27 May 2018

Double jeopardy and the use of QALYs in health care allocation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

27 May 2018

Ahead of its time? Reflecting on New Zealand's Pharmac following its 20th anniversary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

16 August 2018

Assessing the value for money of pharmaceuticals in New Zealand--PHARMAC's approach to cost-utility analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

16 August 2018

Applying Programme Budgeting Marginal Analysis in the health sector: 12 years of experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171589

16 August 2018

The Value of Thinly Spread QALYs

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0208-0

21 January 2018

QALYs and the equity-efficiency trade-off

1 reference

https://pubmed.ncbi.nlm.nih.gov/25209948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Our advice? Get a budget!

1 reference

https://pubmed.ncbi.nlm.nih.gov/25209948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Managing pharmaceutical expenditure while increasing access. The pharmaceutical management agency (PHARMAC) experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/25209948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reconciliation of Economic Concerns and Health Policy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25209948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How New Zealand has contained expenditure on drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/25209948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40273-014-0208-0

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42910043&oldid=2205692140"